One of the recently developed polyamine (PA) analogues, N1,N11-diethylnorspermine (DENSpm), has been found to act as an apoptotic inducer in melanoma, breast, prostate and colon cancer cells. Also, its potential to induce autophagy has been established. Unfolded protein responses and starvation of amino acids are known to trigger autophagy. As yet, however, the molecular mechanism underlying PA deficiency-induced autophagy is not fully clarified. Here, we aimed to determine the apoptotic effect of DENSpm after autophagy inhibition by 3-methyladenine (3-MA) or siRNA-mediated Beclin-1 silencing in colon cancer cells.
The apoptotic effects of DENSpm after 3-MA treatment or Beclin-1 silencing were determined by PI and AnnexinV/PI staining in conjunction with flow cytometry. Intracellular PA levels were measured by HPLC, whereas autophagy and the expression profiles of PA key players were determined in HCT116, SW480 and HT29 colon cancer cells by Western blotting.
We found that DENSpm-induced autophagy was inhibited by 3-MA treatment and Beclin-1 silencing, and that apoptotic cell death was increased by PA depletion and spermidine/spermine N1-acetyltransferase (SSAT) upregulation. We also found that autophagy inhibition led to DENSpm-induced apoptosis through Atg5 down-regulation, p62 degradation and LC3 lipidation in both HCT116 and SW480 cells. p53 deficiency did not alter the response of the colon cancer cells to DENSpm-induced apoptotic cell death under autophagy suppression conditions.
From our results we conclude that DENSpm-induced apoptotic cell death is increased when autophagy is inhibited by 3-MA or Beclin-1 siRNA through PA depletion and PA catabolic activation in colon cancer cells, regardless p53 mutation status.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
N1,N11-bis (ethyl) norspermine
- DiOC6 :
Green Fluorescence Protein
Sodium dodecyl sulphate polyacrylamide gel electrophoresis
K. Igarashi, K. Kashiwagi, Polyamines: Mysterious modulators of cellular functions. Biochem. Biophys. Res. Commun. 271, 559–564 (2000). https://doi.org/10.1006/bbrc.2000.2601
A.E. Pegg, Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res. 48, 759–774 (1988)
N.H. Saab, E.E. West, N.C. Bieszk, C.V. Preuss, A.R. Mank, R.A. Casero Jr., P.M. Woster, Synthesis and evaluation of unsymmetrically substituted polyamine analogues as modulators of human spermidine/spermine-N1-acetyltransferase (SSAT) and as potential antitumor agents. J. Med. Chem. 36, 2998–3004 (1993). https://doi.org/10.1021/jm00072a020
H.C. Ha, P.M. Woster, J.D. Yager, R.A. Casero Jr., The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc. Natl. Acad. Sci. USA 94, 11557–11562 (1997). https://doi.org/10.1073/pnas.94.21.11557
D.L. Kramer, S. Vujcic, P. Diegelman, J. Alderfer, J.T. Miller, J.D. Black, R.J. Bergeron, C.W. Porter, Polyamine analogue induction of the p53-p21WAF1/CIP1-Rb pathway and G1 arrest in human melanoma cells. Cancer Res. 59, 1278–1286 (1999)
Y. Chen, D.L. Kramer, P. Diegelman, S. Vujcic, C.W. Porter, Apoptotic signalling in polyamine analogue-treated SK-MEL-28 human melanoma cells. Cancer Res. 61, 6437–6644 (2001)
G.P. Zagaja, M. Shrivastav, M.J. Fleig, L.J. Marton, C.W. Rinker-Schaeffer, M.E. Dolan, Effects of polyamine analogues on prostatic adenocarcinoma cells in vitro and in vivo. Cancer Chemother. Pharmacol. 41, 505–512 (1998). https://doi.org/10.1007/s002800050774
C. Hegardt, O.T. Johannsson, S.M. Oredsson, Rapid caspase-dependent cell death in cultured human breast cancer cells induced by the polyamine analogue N(1),N(11)-diethylnorspermine. Eur. J. Biochem. 269, 1033–1039 (2002). https://doi.org/10.1046/j.0014-2956.2001.02744.x
H.A. Hahm, D.S. Ettinger, K. Bowling, B. Hoker, T.L. Chen, Y. Zabelina, R.A. Casero Jr., Phase I study of N(1),N(11)-diethylnorspermine in patients with non-small cell lung cancer. Clin. Cancer Res. 8, 684–690 (2002)
A.C. Wolff, D.K. Armstrong, J.H. Fetting, M.K. Carducci, C.D. Riley, J.F. Bender, R.A. Casero, N.E. Davidson, A. Phase II, Study of the polyamine analog N1,N11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancer. Clin. Cancer Res. 9, 5922–5928 (2003)
R.G. Schipper, G. Deli, P. Deloyer, W.P. Lange, J.A. Schalken, A.A. Verhofstad, Antitumor activity of the polyamine analog N(1), N(11)-diethylnorspermine against human prostate carcinoma cells. Prostate 44, 313–321 (2000). https://doi.org/10.1002/1097-0045(20000901)44:4<313::AID-PROS8>3.0.CO;2-D
S. Hector, C.W. Porter, D.L. Kramer, K. Clark, J. Prey, N. Kisiel, P. Diegelman, Y. Chen, L. Pendyala, Polyamine catabolism in platinum drug action: Interactions between oxaliplatin and the polyamine analogue N1,N11-diethylnorspermine at the level of spermidine/spermine N1-acetyltransferase. Mol. Cancer Ther. 3, 813–822 (2004)
W.L. Allen, E.G. McLean, J. Boyer, A. McCulla, P.M. Wilson, V. Coley, D.B. Longley, R.A. Casero, Jr., P.G. Johnston, The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells. Mol. Cancer Ther. 6, 128–137 (2007). https://doi.org/10.1158/1535-7163.MCT-06-0303
Z. Akyol, A. Coker-Gurkan, E.D. Arisan, P. Obakan-Yerlikaya, N. Palavan-Unsal, DENSpm overcame Bcl-2 mediated resistance against paclitaxel treatment in MCF-7 breast cancer cells via activating polyamine catabolic machinery. Biomed. Pharmacother. 84, 2029–2041 (2016). https://doi.org/10.1016/j.biopha.2016.11.016
A. Coker-Gurkan, E.D. Arisan, P. Obakan-Yerlikaya, N. Palavan-Unsal, Lack of functional p53 renders DENSpm-induced autophagy and apoptosis in time dependent manner in colon cancer cells. Amino Acids 47, 87–100 (2015). https://doi.org/10.1007/s00726-014-1851-7
N. Mizushima, Physiological functions of autophagy. Curr. Top. Microbiol. Immunol. 335, 71–84 (2009). https://doi.org/10.1007/978-3-642-00302-8_3
W. Khaodee, N. Inboot, S. Udomsom, W. Kumsaiyai, R. Cressey, Glucosidase II beta subunit (GluIIβ) plays a role in autophagy and apoptosis regulation in lung carcinoma cells in a p53-dependent manner. Cell. Oncol. 40, 579–591 (2017). https://doi.org/10.1007/s13402-017-0349-1
S. Das, A. Nayak, S. Siddharth, D. Nayak, S. Narayan, C.N. Kundu, TRAIL enhances quinacrine-mediated apoptosis in breast cancer cells through induction of autophagy via modulation of p21 and DR5 interactions. Cell. Oncol. 40, 593–607 (2017). https://doi.org/10.1007/s13402-017-0347-3
Z. Yang, D.J. Klionsky, An overview of the molecular mechanism of autophagy. Curr Top Microbiol. Immunol. 335, 1–32 (2009). https://doi.org/10.1007/978-3-642-00302-8_1
S. Pattingre, B. Levine, Bcl-2 inhibition of autophagy: A new route to cancer. Cancer Res. 66, 2885–2888 (2006). https://doi.org/10.1158/0008-5472.CAN-05-4412
W.Y. Choi, E.W. Gerner, L. Ramdas, J. Dupart, J. Carew, L. Proctor, P. Huang, W. Zhang, S.R. Hamilton, Combination of 5-fluorouracil and N-1,N-11-diethylnorspermine markedly activates spermidine/spermine N-1-acetyltransferase expression, depletes polyamines, and synergistically induces apoptosis in colon carcinoma. J. Biol. Chem. 280, 3295–3304 (2005). https://doi.org/10.1074/jbc.M409930200
R. Tummala, P. Diegelman, S.M. Fiuza, L.A.E.B. De Carvalho, M.P.M. Marques, D.L. Kramer, K. Clark, S. Vujcic, C.W. Porter, L. Pendyala, Characterization of Pt-, Pd-spermine complexes for their effect on polyamine pathway and cisplatin resistance in A2780 ovarian carcinoma cells. Oncology Rep. 24, 15–24 (2010)
Z.P. Xie, D.J. Klionsky, Autophagosome formation: Core machinery and adaptations. Nature Cell Biol. 9, 1102–1109 (2007)
E. Morselli, E. Tasdemir, M.C. Maiuri, L. Galluzzi, O. Kepp, A. Criollo, J.M. Vicencio, T. Soussi, G. Kroemer, Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle 7, 3056–3061 (2008). https://doi.org/10.4161/cc.7.19.6751
E. Kim, A. Giese, W. Deppert, Wild-type p53 in cancer cells: When a guardian turns into a blackguard. Biochem. Pharmacol. 77, 11–20 (2009). https://doi.org/10.1016/j.bcp.2008.08.030
A. Pledgie-Tracy, M. Billam, A. Hacker, M.D. Sobolewski, P.M. Woster, Z. Zhang, R.A. Casero, N.E. Davidson, The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines. Cancer Chemother. Pharmacol. 65, 1067–1081 (2010). https://doi.org/10.1007/s00280-009-1112-8
H.M. Wallace, A.V. Fraser, A. Hughes, A perspective of polyamine metabolism. Biochem J. 376, 1–14 (2003). https://doi.org/10.1042/bj20031327
Y. Chen, D.L. Kramer, F. Li, C.W. Porter, Loss of inhibitor of apoptosis proteins as a determinant of polyamine analogue-induced apoptosis in human melanoma cells. Oncogene 22, 4964–4972 (2003). https://doi.org/10.1038/sj.onc.1206725
D.E. McCloskey, J. Yang, P.M. Woster, N.E. Davidson, R.A. Casero, Jr., Polyamine analogue induction of programmed cell death in human lung tumor cells. Clin. Cancer Res. 2, 441–446 (1996)
S.M. Oredsson, K, Alm, E. Dahlberg, C.M. Holst, V.M. Johansson, L. Myhre, E. Soderstjerna, inhibition of cell proliferation and induction of apoptosis by N(1),N(11)-diethylnorspermine-induced polyamine pool reduction. Biochem. Soc. Trans. 35, 405–409 (2007). https://doi.org/10.1042/BST0350405
B.K. Chang, Y. Liang, D.W. Miller, R.J. Bergeron, C.W. Porter, G. Wang, Effects of diethyl spermine analogues in human bladder cancer cell lines in culture. J. Urol. 150, 1293–1297 (1993). https://doi.org/10.1016/S0022-5347(17)35763-4
C.W. Porter, B. Ganis, P.R. Libby, R.J. Bergeron, Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. Cancer Res. 51, 3715–3720 (1991)
D.E. McCloskey, A.E. Pegg, Altered spermidine/spermine N1-acetyltransferase activity as a mechanism of cellular resistance to bis (ethyl) polyamine analogues. J. Biol. Chem. 275, 28708–28714 (2000). https://doi.org/10.1074/jbc.M004120200
S. Sinha, B. Levine, The autophagy effector Beclin 1: A novel BH3-only protein. Oncogene 27, 137–148 (2008)
This work was supported by The Scientific and Technological Research Council of TURKEY [(TUBITAK), Grant Number; 212T227] and the Istanbul Kultur University Scientific Projects Support Center. We are thankful to Esin Guvenir, Merve Karatas and Derya Bulut for their technical assistance.
Conflict of interest
The authors declare that they have no conflict of interest.
About this article
Cite this article
Gurkan, A.C., Arisan, E.D., Yerlikaya, P.O. et al. Inhibition of autophagy enhances DENSpm-induced apoptosis in human colon cancer cells in a p53 independent manner. Cell Oncol. 41, 297–317 (2018). https://doi.org/10.1007/s13402-017-0369-x
- Colon cancer
- Polyamine analogue